Advanced Biomed (ADVB) Cash from Investing Activities (2024 - 2026)
Advanced Biomed's (ADVB) quarterly Cash from Investing Activities came in at -$1264.0 in Q1 2026, up 42.93% year-on-year from -$884.32 in Q1 2025, and up 90.21% quarter-over-quarter from -$12906.0 in Q4 2025.
Advanced Biomed (ADVB) Cash from Investing Activities (2024 - 2026) Analysis & Trends
Advanced Biomed has disclosed Cash from Investing Activities across 3 years of filings, most recently posting -$1264.0 for Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$1264.0, up 42.93% year-over-year; the trailing twelve-month figure through Mar 2026 was -$36090.0 (up 44.27% YoY), and the FY2025 annual result was -$31650.0, up 57.29% from the prior year.
- Cash from Investing Activities came in at -$1264.0 for Q1 2026 at Advanced Biomed, up from -$12906.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $26699.0 in Q1 2024 to a low of -$53256.0 in Q2 2024.
- The 3-year median for Cash from Investing Activities is -$2215.0 (2025), against an average of -$8238.7.
- Peak annual rise in Cash from Investing Activities reached 91.14% in 2025, while the deepest fall reached 220.71% in 2025.
- Advanced Biomed's Cash from Investing Activities stood at $10692.0 in 2024, then slumped by 220.71% to -$12906.0 in 2025, then soared by 90.21% to -$1264.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$1264.0 (Q1 2026), -$12906.0 (Q4 2025), and -$1771.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | -77.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -196.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -32.14 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Advanced Biomed | - | - | - | -1,264.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,264.00 |
| Mar 31, 2026 | -1,264.00 |
| Dec 31, 2025 | -12,906.00 |
| Dec 31, 2025 | -12,906.00 |
| Sep 30, 2025 | -1,771.00 |
| Sep 30, 2025 | -1,771.00 |
| Jun 30, 2025 | -20,149.00 |
| Jun 30, 2025 | -20,149.00 |
| Mar 31, 2025 | -2,215.00 |
| Mar 31, 2025 | -2,215.00 |
| Dec 31, 2024 | 10,692.00 |
| Dec 31, 2024 | 10,692.00 |
| Sep 30, 2024 | -19,978.00 |
| Sep 30, 2024 | -19,978.00 |
| Jun 30, 2024 | -53,256.00 |
| Jun 30, 2024 | -53,256.00 |
| Mar 31, 2024 | 26,699.00 |
| Mar 31, 2024 | 26,699.00 |